Medtronic CoreValve Multi-Center Study Shows Rapid and Sustained Health-Related Quality-of-Life Improvements

New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life benefits for patients receiving the Medtronic CoreValve® System from Medtronic, Inc. MDT. The favorable two-year results from the 18-French CoreValve multicenter prospective study are the largest set of CoreValve HRQoL data and the longest-term HRQoL data available from all transcatheter aortic valve implantation systems.